Replimune Group Stock

Replimune Group FCF per Share

The Free Cash Flow per Share of Replimune Group (REPL) as of Aug 12, 2026 is -3.07 USD. In the previous year, Free Cash Flow per Share was -2.16 USD — a change of 42.09% (lower).

FCF per Share

-3.07USD

YoY

42.09%

Last updated:

Free Cash Flow per Share of Replimune Group is 2026 -3.07 USD. Free Cash Flow per Share of Replimune Group was 2025 -2.16 USD. It decreases by 42.09% lower compared to the previous year.
Access this data via the Eulerpool API

Replimune Group Stock analysis

What does Replimune Group do? Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Replimune Group stock

Free Cash Flow per Share of Replimune Group is -3.07 USD in 2026.

Free Cash Flow per Share of Replimune Group changed from -2.16 USD to -3.07 USD, representing a 42.09% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Replimune Group since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

Cash Flow — Replimune Group

All Key Metrics — Replimune Group